{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?QuestionStatus=Tabled&max-ddpModified.=2018-03-06T00%3A02%3A26.334Z&AnswerDate=2018-03-08", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?QuestionStatus=Tabled&max-ddpModified.=2018-03-06T00%3A02%3A26.334Z&AnswerDate=2018-03-08", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?QuestionStatus=Tabled&max-ddpModified.=2018-03-06T00%3A02%3A26.334Z&AnswerDate=2018-03-08&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&QuestionStatus=Tabled&max-ddpModified.=2018-03-06T00%3A02%3A26.334Z&AnswerDate=2018-03-08", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?QuestionStatus=Tabled&max-ddpModified.=2018-03-06T00%3A02%3A26.334Z&AnswerDate=2018-03-08", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?QuestionStatus=Tabled&max-ddpModified.=2018-03-06T00%3A02%3A26.334Z&AnswerDate=2018-03-08", "items" : [{"_about" : "http://data.parliament.uk/resources/855487", "AnsweringBody" : [{"_value" : "Department for Digital, Culture, Media and Sport"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/855487/answer", "answerText" : {"_value" : "
DCMS does not centrally collect the specific data requested.<\/p>
<\/p>
Information regarding contracts above the value of £10,000 is published on Contracts Finder on GOV.UK, available at https://www.gov.uk/contracts-finder.<\/p>
<\/p>
The Interception of Communications Commissioner and the Information Commissioner\u2019s Office also have responsibilities in this area.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4115", "label" : {"_value" : "Biography information for Margot James"} } , "answeringMemberConstituency" : {"_value" : "Stourbridge"} , "answeringMemberPrinted" : {"_value" : "Margot James"} , "dateOfAnswer" : {"_value" : "2018-03-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-08T11:43:44.617Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "10"} , "answeringDeptShortName" : {"_value" : "Digital, Culture, Media and Sport"} , "answeringDeptSortName" : {"_value" : "Digital, Culture, Media and Sport"} , "date" : {"_value" : "2018-03-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Department for Digital, Culture, Media and Sport: Internet"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Digital, Culture, Media and Sport, what estimate he has made of the volume of UK citizens\u2019 data held by companies (a) supplying cloud services to his department and (b) contracted to deliver cloud services on behalf of his Department that is subject to information requests from US Government bodies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/261", "label" : {"_value" : "Biography information for James Gray"} } , "tablingMemberConstituency" : {"_value" : "North Wiltshire"} , "tablingMemberPrinted" : [{"_value" : "James Gray"} ], "uin" : "130794"} , {"_about" : "http://data.parliament.uk/resources/855490", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/855490/answer", "answerText" : {"_value" : "
I welcome the National Police Chiefs\u2019 Council\u2019s and Association of Police and Crime Commissioner\u2019s swift action to minimise the impact on the criminal justice system and protect evidence for live cases. The contractual arrangements are a commercial matter for the police and the company.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1561", "label" : {"_value" : "Biography information for Mr Nick Hurd"} } , "answeringMemberConstituency" : {"_value" : "Ruislip, Northwood and Pinner"} , "answeringMemberPrinted" : {"_value" : "Mr Nick Hurd"} , "dateOfAnswer" : {"_value" : "2018-03-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-08T17:45:34.453Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2018-03-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Key Forensic Services: Insolvency"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Home Department, pursuant to the Answer of 26 February 2018 to Question 128775, on Key Forensic Services: Insolvency, which police forces were contracted with Key Forensic Services prior to that company entering administration.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4473", "label" : {"_value" : "Biography information for Louise Haigh"} } , "tablingMemberConstituency" : {"_value" : "Sheffield, Heeley"} , "tablingMemberPrinted" : [{"_value" : "Louise Haigh"} ], "uin" : "130797"} , {"_about" : "http://data.parliament.uk/resources/855493", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/855493/answer", "answerText" : {"_value" : "
The information requested is shown in the table below.<\/p>
<\/p>
Number of Employment and Support Allowance (ESA) claimants with at least one work capability assessment outcome, with a main disabling condition of Cystic Fibrosis, Motor Neurone Disease, Multiple Sclerosis, Parkinson\u2019s Disease or Rheumatoid Arthritis, by assessment type, assessment outcome and year 20082<\/sup> to 20174<\/sup>, Great Britain<\/strong><\/p> <\/strong><\/p><\/td> <\/strong><\/p><\/td> \u2018000s<\/em><\/strong><\/p><\/td><\/tr> Condition<\/strong><\/p><\/td> Year of completed assessment<\/strong><\/p><\/td><\/tr> Assessment type - Outcome<\/p><\/td> 08<\/strong><\/p><\/td> 09<\/strong><\/p><\/td> 10<\/strong><\/p><\/td> 11<\/strong><\/p><\/td> 12<\/strong><\/p><\/td> 13<\/strong><\/p><\/td> 14<\/strong><\/p><\/td> 15<\/strong><\/p><\/td> 16<\/strong><\/p><\/td> 17<\/strong><\/p><\/td> Total<\/strong><\/p><\/td><\/tr> Cystic Fibrosis<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 1.0<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.6<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.6<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Motor Neurone Disease<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 1.5<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 0.3<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.2<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Multiple Sclerosis<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.5<\/p><\/td> 0.7<\/p><\/td> 0.9<\/p><\/td> 1.5<\/p><\/td> 1.3<\/p><\/td> 1.8<\/p><\/td> 1.5<\/p><\/td> 1.1<\/p><\/td> 0.7<\/p><\/td> 9.7<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> 0.7<\/p><\/td> 0.9<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 2.8<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> 0.4<\/p><\/td> 0.4<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 2.2<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.8<\/p><\/td> 2<\/p><\/td> 2<\/p><\/td> 1.8<\/p><\/td> 0.4<\/p><\/td> 3.7<\/p><\/td> 1.1<\/p><\/td> 9.7<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.4<\/p><\/td> 0.6<\/p><\/td> 0.7<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> 1.7<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.5<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 1.4<\/p><\/td> 4.2<\/p><\/td> 7<\/p><\/td> 2.3<\/p><\/td> 0.7<\/p><\/td> 0.5<\/p><\/td> 0.1<\/p><\/td> 16.2<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.5<\/p><\/td> 1.1<\/p><\/td> 0.9<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 2.6<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.3<\/strong><\/p><\/td><\/tr> Parkinsons Disease<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.4<\/p><\/td> 0.4<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 2.1<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.8<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.8<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.4<\/p><\/td> 0.1<\/p><\/td> 1.3<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.4<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.6<\/p><\/td> 0.2<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 1.3<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.3<\/strong><\/p><\/td><\/tr> IBR - Fit for Work<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/p><\/td> -<\/strong><\/p><\/td><\/tr> Rheumatoid Arthritis<\/strong><\/p><\/td><\/tr> Initial - Support Group<\/p><\/td> -<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.6<\/p><\/td> 0.6<\/p><\/td> 1.0<\/p><\/td> 0.9<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 4.5<\/strong><\/p><\/td><\/tr> Initial - WRAG<\/p><\/td> -<\/p><\/td> 0.7<\/p><\/td> 0.9<\/p><\/td> 0.6<\/p><\/td> 0.6<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 3.7<\/strong><\/p><\/td><\/tr> Initial - Fit for Work<\/p><\/td> -<\/p><\/td> 0.8<\/p><\/td> 0.9<\/p><\/td> 0.6<\/p><\/td> 0.7<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 0.6<\/p><\/td> 0.6<\/p><\/td> 0.3<\/p><\/td> 5.2<\/strong><\/p><\/td><\/tr> Repeat - Support Group<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.8<\/p><\/td> 1.4<\/p><\/td> 1.5<\/p><\/td> 0.4<\/p><\/td> 1.9<\/p><\/td> 0.8<\/p><\/td> 5.9<\/strong><\/p><\/td><\/tr> Repeat - WRAG<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.4<\/p><\/td> 0.8<\/p><\/td> 1.2<\/p><\/td> 0.8<\/p><\/td> 0.4<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 3<\/strong><\/p><\/td><\/tr> Repeat - Fit For Work<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.1<\/p><\/td> 0.4<\/p><\/td> 0.2<\/p><\/td> 1.7<\/strong><\/p><\/td><\/tr> IBR - Support Group<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.5<\/p><\/td> 1.5<\/p><\/td> 2.6<\/p><\/td> 1.1<\/p><\/td> 0.5<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> 6.6<\/strong><\/p><\/td><\/tr> IBR - WRAG<\/p><\/td> .<\/p><\/td> .<\/p><\/td> .<\/p><\/td> 0.8<\/p><\/td> 2.2<\/p><\/td> 1.7<\/p><\/td> 0.3<\/p><\/td> 0.1<\/p><\/td> -<\/p><\/td> -<\/p><\/td> 5<\/strong><\/p><\/td><\/tr>